Articles related to "Brca2"

A study presented at the 2009 ASCO meeting, shows the efficiency and low toxicity of a new inhibitor of the PARP protein, in patients resistant to standard chemotherapy.

Once a woman makes the decision to undergo hereditary breast cancer testing, she must be prepared for what either positive or negative test results mean in her life.

BRACAnalysis is a new development that tests patients for mutations in genes that lead to breast cancer.

One in 8 women will develop breast cancer in her lifetime. Women at high risk should be screened more often and may need preventative medications or surgery.

Mutations in the so-called breast cancer genes account for only around 5% of breast cancers. Around the world, the search for other high risk genes is continuing.

New technologies help researchers find common genetic mutations in different cancers.

Is knowledge power or is ignorance bliss? It's a question that can divide families when it comes to testing for abnormal BRCA1 and BRCA2 genes.

BRCA1 and BRCA2 may have been named after breast cancer, but mutations in the genes also increase the lifetime risk of ovarian cancer by up to 50%.

Why testing is recommended before symptoms of breast cancer. Breast cancer facts about cancer risks. Breast cancer statistics about risk levels.

According to the American Cancer Society (ACS), women have a five-year survival rate of nearly 93 percent if ovarian cancer is found in the earliest stages.

Twelve genetic variants, also called single nucleotide polymorphisms, known as risk factors of prostate cancer, have also been analyzed in ovarian and breast cancers.

Breast cancer in men is found in 1% of all breast cancer cases. Although this is rare, men need to be aware that they are not immune from this form of carcinoma.

A nick in the DNA strand is known as a chromosomal break. Cells have repair mechanisms for both single strand and double strand breaks.

Breast cancer is one of the leading health concerns in the United States; 1 in 8 women is affected. Traditional screening methods may not be reducing mortality.

OvPlex is a new blood test that detects ovarian cancer in the early stages. This article explains what ovarian cancer is, different types, symptoms, and treatments.